AstraZeneca Hit by a Flood of Patent Challenges to Crestor

AstraZeneca says it filed patent infringement actions in the USA against seven drugmakers who are trying to get their generic versions of the blockbuster cholesterol lowerer Crestor approved for marketing.
PharmaTimes